Delivery Order SPE2DR25D1103-SPE2DR26FE402
Award Date 12/16/25
Potential Completion Date 12/17/25
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,466.94 to AmerisourceBergen Drug Corp for LINZESS 72 MCG capsules (30-count unit) on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. LINZESS is a prescription medication used to treat irritable bowel syndrome with...
- The Defense Logistics Agency awarded a $1,116.04 firm fixed price delivery order to AmerisourceBergen Drug Corp for LINZESS 145 microgram capsules (30-count unit of use packaging) on August 26, 2025, with an ultimate completion date of August 27, 2025. This non-competitive delivery order is issued under the vendor's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency awarded a $3,612.68 delivery order to AmerisourceBergen Drug Corp for LINZESS 290 microgram capsules (30-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. LINZESS is a prescription medication used to treat chronic idiopathic constipation and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for LINZESS 72 MCG capsules (30-count units) with a ceiling value of $1,334.42. This firm fixed-price delivery order, issued on December 3, 2025, with an ultimate completion date of December 4, 2025, represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for LINZESS 145 MCG capsules (30-count units) on August 6, 2025, with a ceiling value of $5,326.68. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 7, 2025. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $3,960.50 delivery order to AmerisourceBergen Drug Corp for 30 capsules of Linzess 72 micrograms on December 9, 2025, with a completion date of December 10, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX. The IDC, valued at $999,999,999.00 and extending through...
- This delivery order, awarded September 4, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides 30 capsules of Linzess 145 MCG under a firm fixed price contract valued at $8,016.10, with completion expected by September 5, 2025. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle that runs through December 2026. The contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,601.24 to AmerisourceBergen Drug Corp for LINZESS 145 microgram capsules (30-count units). This competitively awarded, firm fixed-price contract was issued on December 12, 2025, with a completion date of December 15, 2025. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. No set-aside designation was applied to this...
- The Defense Logistics Agency (DLA) awarded a $2,355.01 delivery order to AmerisourceBergen Drug Corp for Linzess 145 mcg capsules (30-count units) on December 3, 2025, with an ultimate completion date of December 4, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work is performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,333.53 to AmerisourceBergen Drug Corp for Linzess 72 mcg capsules (30-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order was performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competed among all eligible vendors in the open market. This delivery order is...